Top compounds associated with response to LIPJ


Feature Type Standardized
Nominal ANOVA
mRNA ruxolitinib GDSC1000 pan-cancer AAC -0.065 0.05
mRNA Zibotentan GDSC1000 pan-cancer AAC -0.065 0.05
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.068 0.05
mRNA AZD1480 CTRPv2 pan-cancer AAC 0.1 0.06
mRNA JQ-1 GDSC1000 pan-cancer AAC 0.062 0.06
mRNA Bosutinib CTRPv2 pan-cancer AAC 0.064 0.06
mRNA epigallocatechin-3-monogallate CTRPv2 pan-cancer AAC 0.066 0.06
mRNA Sorafenib CCLE pan-cancer AAC -0.084 0.06
mRNA masitinib GDSC1000 pan-cancer AAC -0.059 0.07
mRNA MK-2206 GDSC1000 pan-cancer AAC -0.064 0.08
Download CSV